Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study

M. D. Bellin, G. J. Beilman, T. B. Dunn, T. L. Pruett, D. E.R. Sutherland, S. Chinnakotla, J. S. Hodges, A. Lane, P. Ptacek, K. L. Berry, B. J. Hering, A. Moran

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Insulin independence after total pancreatectomy and islet autotransplant (TPIAT) for chronic pancreatitis is limited by a high rate of postprocedure beta cell apoptosis. Endogenous glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, which are increased by dipeptidyl peptidase 4 inhibitor therapy (sitagliptin) may protect against beta cell apoptosis. To determine the effect of sitagliptin after TPIAT, 83 adult TPIAT recipients were randomized to receive sitagliptin (n = 54) or placebo (n = 29) for 12 months after TPIAT. At 12 and 18 months after TPIAT, participants were assessed for insulin independence; metabolic testing was performed with mixed meal tolerance testing and frequent sample intravenous glucose tolerance testing. Insulin independence did not differ between the sitagliptin and placebo groups at 12 months (42% vs. 45%, p = 0.82) or 18 months (36% vs. 44%, p = 0.48). At 12 months, insulin dose was 9.0 (standard error 1.7) units/day and 7.9 (2.2) units/day in the sitagliptin and placebo groups, respectively (p = 0.67) and at 18 months 10.3 (1.9) and 7.1 (2.6) units/day, respectively (p = 0.32). Hemoglobin A1c levels and insulin secretory measures were similar in the two groups, as were adverse events. In conclusion, sitagliptin could be safely administered but did not improve metabolic outcomes after TPIAT.

Original languageEnglish (US)
Pages (from-to)443-450
Number of pages8
JournalAmerican Journal of Transplantation
Issue number2
StatePublished - Feb 1 2017

Bibliographical note

Publisher Copyright:
© Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons


  • clinical research/practice
  • clinical trial
  • diabetes
  • graft survival
  • insulin/C-peptide
  • islet transplantation
  • islets of Langerhans


Dive into the research topics of 'Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study'. Together they form a unique fingerprint.

Cite this